Juan A Mantelle

This inventor holds 30 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 4 EPO patents, primarily in Transdermal Drug Delivery. Top assignees: Noven Pharmaceuticals, Inc., Dow Corning Corporation, Nover Pharmaceuticals, Inc.. Active years: 1993-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan A Mantelle. Retrieved from https://idiyas.com/inventor/juan-a-mantelle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 8)

% Patents Active = 76.7

CIPO Patents = 8 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 1.8

ph-index = 18

Forward Citations = 1,902(Granted Patents)

Company Filing History:

27 out of 93

Noven Pharmaceuticals, Inc.

patents

1 out of 2,921

Dow Corning Corporation

patents

1 out of 1

Nover Pharmaceuticals, Inc.

Years Active: 1993-2019

Loading Chart...

Areas of Expertise:

Transdermal Delivery

Lidocaine

Estrogen

Testosterone

Drug Flux Control

Bioadhesive Compositions

Packaging System

Acrylic Adhesive Polymers

Low Molecular Weight Drugs

Attention Deficit Disorder

Solubility Enhancement

Topical Administration

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10307380 - Composition and method for transdermal lidocaine delivery (2019-06-04),

2. 10231938 - Transdermal drug delivery device including an occlusive backing (2019-03-19),

3. 9833419 - Transdermal estrogen device and delivery (2017-12-05),

4. 9730900 - Transdermal estrogen device and delivery (2017-08-15),

5. 9724310 - Transdermal estrogen device and delivery (2017-08-08),

6. 9320742 - Transdermal testosterone device and delivery (2016-04-26),

7. 9155712 - Transdermal drug delivery device including an occlusive backing (2015-10-13),

8. 8815281 - Transdermal drug delivery device including an occlusive backing (2014-08-26),

9. 8715723 - Compositions and methods for delivery of amino-functional drugs (2014-05-06),

10. 8703175 - Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems (2014-04-22),

11. 8591941 - Transdermal drug delivery device including an occlusive backing (2013-11-26),

12. 8337884 - Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures (2012-12-25),

13. 8231906 - Transdermal estrogen device and delivery (2012-07-31),

14. 8216606 - Dermal composition for controlling drug flux comprising two acrylic adhesive polymers having different functionalities and different solubility parameters (2012-07-10),

15. 8187628 - Dermal composition for controlling drug flux comprising two acrylic adhesive polymers having different functionalities and different solubility parameters (2012-05-29),

Title: Juan A Mantelle: Pioneering Innovator in Transdermal Drug Delivery

Introduction:

Juan A Mantelle, a visionary inventor based in Miami, FL, is an inspirational figure in the field of innovation. With a portfolio of 30 patents and a relentless pursuit of excellence, he continues to pave the way for the next generation of inventors.

Latest Patents:

Mantelle's latest patents showcase his expertise in transdermal drug delivery. One of his groundbreaking inventions includes a Composition and method for transdermal lidocaine delivery, revolutionizing the manufacturing process of lidocaine patches for enhanced performance and stability. Additionally, his Transdermal drug delivery device brings a unique approach to controlling the delivery rate and profile of active agents through an occlusive backing layer.

Career Highlights:

Having worked with renowned companies like Noven Pharmaceuticals, Inc., Mantelle has honed his skills and expertise in pharmaceutical innovation. His contribution to the field has not only resulted in numerous patents but also in advancing the technology of transdermal drug delivery systems.

Collaborations:

Throughout his career, Mantelle has collaborated with industry experts such as David P Kanios and David Houze. Together, they have pushed the boundaries of innovation, setting new standards in the pharmaceutical industry.

Conclusion:

Juan A Mantelle's passion for innovation and his unwavering determination to make a difference stand as a testament to the impact of creativity and perseverance. Through his groundbreaking inventions and collaborations, Mantelle continues to inspire and shape the future of inventors worldwide.

Profile summary based on public USPTO records.